Cartesian Therapeutics, Inc. Common Stock
XNAS:RNAC
8.2
$9.17 - 100.00
$5.58 - 100.00
$7.67
$8.34
$8.07
$8.12
20.12
5.98
271517
230162.7
8864653.24
Chart
TendieTensor AI Analysis
Company
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
Fundamentals
66
-0.160000
-5.948800
100
BBG001J19Q25
BBG001V0FQQ0
26.00M
26.00M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own RNAC. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.